News & Updates
Filter by Specialty:

Ultra-high-dose methylcobalamin may reduce clinical progression in early-stage ALS
01 Jul 2022
byAudrey Abella
Ultra-high-dose methylcobalamin (MeCbl) slowed functional decline in individuals with early-stage amyotrophic lateral sclerosis (ALS) with moderate progression, the JETALS* study has shown.
Ultra-high-dose methylcobalamin may reduce clinical progression in early-stage ALS
01 Jul 2022
Diabetes, fertility treatment, family history up autism risk in infants
26 Jun 2022
A recent Egypt study has identified several maternal and neonatal factors contributing to the risk of autism spectrum disorders (ASD) in infants, including the use of assisted fertility treatments, family medical history, and threatened abortion.
Diabetes, fertility treatment, family history up autism risk in infants
26 Jun 2022
Ketogenic trials with Parkinson’s disease-specific outcomes lacking
19 Jun 2022
The ketogenic diet, as well as ketogenic agents, has been shown to be a promising therapeutic regimen for Parkinson’s disease (PD) in animals, but research on humans is highly heterogenous and lacking PD-specific outcomes, according to a study.